跳至主要内容
临床试验/NCT03487146
NCT03487146已完成不适用

Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients

Shanghai Pudong Hospital0 个研究点目标入组 156 人开始时间: 2015年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
156
主要终点
improvement of self-reported sleep disturbance

研究概览

简要总结

Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • duration of maintenance HD should be equal or more than 3 months,
  • patient's age should be equal or more than 18 years

排除标准

  • i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study
  • he/she has received a short-term poor prognosis
  • he/she would be more than 80 years old

研究组 & 干预措施

HD(hemodialysis) group

No Intervention

HD group as conventional control arm

HD+HP(hemodialysis+hemoperfusion) group

Active Comparator

HD+HP as active interventional group.HP was performed 1-2 times/per 2 weeks, and each session lasted for two hours.

干预措施: hemoperfusion(HP) (Device)

结局指标

主要结局

improvement of self-reported sleep disturbance

时间窗: 2 years

Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire

次要结局

  • survival(2 years)

研究者

发起方
Shanghai Pudong Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin HM, MD

Professor

Shanghai Pudong Hospital

相似试验